NCT06575374View on ClinicalTrials.gov

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

PHASE2RecruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2027

Conditions

Cell Therapy

Interventions

DRUG

Letermovir

Given by mouth or intravenously

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER